Clinical Trial Update: Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cannabidiol to reduce postoperative opioid use after primary total knee arthroplasty. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of Knee

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Chad Brummett | Conditions: Knee Replacement Surgery, Osteoarthritis, Knee | Phase 2 | Status: RECRUITING